Abetimus Uses, Dosage, Side Effects and more
Abetimus was developed by La Jolla Pharmaceuticals as an immunosuppressant but was never marketed in American or Europe despite application for marketing authorization in the mid-2000s.
| Trade Name | Abetimus |
| Generic | Abetimus |
| Abetimus Other Names | Abetimus |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in kidney disease and systemic lupus erythematosus.
